Life Sciences Licensing and Collaboration Deals: Antitrust Traps for the Unwary
With an uptick in antitrust enforcement action across the US, UK, EU and China (among other jurisdictions), companies in the life...
Kristen Riemenschneider's Passles
Freshfields Technology Quotient
Insights at the intersection of technology and the law
Most Read
Could the Specter of March-In Rights Finally Impact Drug Pricing Reform?
On March 24, 2022 a group of public interest organizations filed a petition urging the Department of Health and Human Services (“HHS”) to...
Is it time for big biopharma companies to rethink the use of federal funding for R&D?
This article was originally published in STAT on January 18, 2022.
I have been negotiating with representatives of the federal...
Is it time for big biopharma companies to rethink the use of federal funding for R&D?
This article was originally published in STAT on January 18, 2022.
I have been negotiating with representatives of the federal...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net
